Vinati Organics (524200) Q3 25/26 earnings summary
Event summary combining transcript, slides, and related documents.
Q3 25/26 earnings summary
7 Sep, 2026Executive summary
Board approved unaudited standalone and consolidated financial results for Q3 and nine months ended December 31, 2025.
Limited review reports issued by statutory auditors for both standalone and consolidated results, with no qualifications.
Amendments made to key governance policies, including dividend distribution, related party transactions, whistle blower, insider trading, and fair disclosure codes.
Financial highlights
Standalone Q3 FY26 revenue from operations: ₹529.14 crore, up from ₹521.67 crore YoY; nine months revenue: ₹1,617.67 crore.
Standalone Q3 net profit: ₹108.47 crore, up from ₹95.55 crore YoY; nine months net profit: ₹350.28 crore.
Consolidated Q3 FY26 revenue from operations: ₹530.78 crore, up from ₹521.68 crore YoY; nine months revenue: ₹1,622.97 crore.
Consolidated Q3 net profit: ₹100.83 crore, up from ₹93.70 crore YoY; nine months net profit: ₹319.89 crore.
Basic and diluted EPS (standalone) for Q3: ₹10.46; (consolidated) for Q3: ₹9.73.
Outlook and guidance
Financial statements prepared in accordance with Ind AS and reviewed by audit committee and board.
Latest events from Vinati Organics
- Strong revenue and profit growth reported for Q1 FY25, with robust performance in chemicals manufacturing.524200
Q1 24/25 - Strong year-over-year growth in revenue and profit, with robust cash flow and equity position.524200
Q2 24/25 - Q3 and nine-month results show strong growth and US expansion plans approved.524200
Q3 24/25 - FY25 saw robust profit growth, a Rs.7.50 dividend, and expansion with a new US subsidiary.524200
Q4 24/25 - Q1 margin rose to 30% on lower costs; year-over-year profit and revenue growth with strong outlook.524200
Q1 25/26 - Margins expanded and profits rose, supported by capacity growth and a CFO transition.524200
Q2 25/26 - Strong Q4 growth, robust audited results, and double-digit volume growth targeted for FY 2027.524200
Q4 25/26 - Revenue and profit rose with stable margins; capacity expansion to support future growth.524200
Q1 26/27